Searchable abstracts of presentations at key conferences in endocrinology

ea0031p211 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

The use of GLP-1 receptor agonists to manage unwanted weight gain in patients with ‘hypothalamic’ obesity secondary to structural pituitary pathology

Kyaw Ye , Mogford Julianne , Hordern Victoria , Russell-Jones David

Introduction:: The hypothalamus is intimately involved in weight homeostasis. Pituitary tumours and treatment for pituitary tumours has been well described to induce obesity in certain subjects presumably due hypothalamic irritation or dysfunction. This is often very challenging to treat.GLP-1 analogues have direct central effects and have been shown to be effective for weight loss in obese patients with and without diabetes mellitus.<p class="abstex...